Marco Koch Email & Phone Number

Brussels, Be

In my new role I am driving the strategic planning for Neurology assets in our early R&D portfolio. The mandate is to ensure that our development strategies are patient value-focussed, evidence-based and commercially viable. It's about building bridges between internal stakeholders and partnering with our external communities (from medics to patients). This allows us to set the right course for our programs and define 'where to play' (choosing the best indications) and 'how to win' (creating winning value propositions) - with our patients at the heart.

Brussels, Be

I've joined UCB Biopharma at their Brussels headquarters. As Early Evidence Lead, I help amplifying the patient perspective from the start in early drug development (from discovery research to proof-of-concept stage). Working in a multi-disciplinary team together with Access, RWE and CI colleagues, we are tasked to build a robust integrated evidence base for these early assets to maximize their ultimate value to patients. Very excited about this challenge, fully dedicated to patient insights & engagement …

Offering strategic advisory and project management services in China and Europe on the health and life-science sector. Helped research & consulting firms develop cutting-edge market intelligence, real-world data & analytics offerings and promote their international business.KEY PROJECTS* Interim Management // External Insights & Analytics project manager for a corporate pharma unit (Germany)* Go-to-Market Intelligence // International market access landscape review for a pre-launch specialty drug (Germany)* BD Coaching // Life-science client engagement strategies for MR agencies & Big Data start-ups (China, Germany)* Public Health (RWE) Research // Collaborative patient research with Peking University & Kantar Health (China)

Chaoyang, Beijing, Cn

HSK 3 level successfully completed (score 291/300)

Shanghai, Shanghai, Cn

Independent advisor to Go Capture, a strategic data analytics and consulting company providing data insights to answer some of the “big questions” business leaders need to compete and win in the China market. Go Capture partners with several of China’s major internet providers, which enables Go Capture to provide rich digital insights based on extensive proprietary datasets, including the browsing behavior of currently 300 million Chinese consumers.We worked together on dedicated insight solutions for the Pharma/OTC/MedTech industry, which help clients gain and retain a leading edge by navigating the booming digital health space in China.

Frankfurt Am Main, De

Re-organized and -aligned staff resources to form an integrated corporate competence center (5 reports) which could address both global and domestic MR & CI demands of the transforming organization. Developed joint new vision, lean structures and agile collaboration principles to future-proof the function. Helped business partners to leverage market opportunities, uncover risks and create impactful business solutions, based on sound market and customer insights. Key therapeutic areas included CNS/movement disorders (neurotoxins) and aesthetic medicine (neurotoxins, dermal fillers, capital equipment).

Frankfurt Am Main, De

Built from scratch (up to a team of 3 reports) a leading global market intelligence function which effectively supported the strategic marketing units and corporate management in their strategic and operative decision making. Appointed to Director in 2010.Therapeutic areas included CNS (Alzheimer’s Disease, Parkinson’s Disease, movement disorders), Dermatology (aesthetic, therapeutic) and OTC/X (metabolism, skin care).

Us

As BI MANAGER within the corporate R&D Business Development unit, provided critical input and consultation on market, competition and business environment. Championed assessment and valuation of new project opportunities and the development of pipeline filling strategies in the therapeutic areas neurology, pain and urology/prostate cancer.As MR MANAGER GERMANY, delivered market performance reports, synthesizing primary and secondary data; undertook qualitative and quantitative ad-hoc research; supported analysis and forecasting of new business projects. Therapeutic areas included CV, GI, respiratory diseases, OTC/VMS.

Düsseldorf, De

Marketing consultancy services provided for industry clients, conducting brand and communications research using both quantitative and qualitative methods.Business sectors included FMCG, Automotive, Hospitality, Consumer Health.

New York, Ny, Us